MX01LA010006
MX01LA010006
GENOMMA LAB INTERNACIONAL SAB
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 12.75B EUR | 14.65B EUR | 17.76B EUR | 17.51B EUR |
Enterprise Value | 17.91B EUR | 19.98B EUR | 23B EUR | 22.3B EUR |
Valuation Multiples | ||||
Trailing P/E | 7.86x | 12.32x | 15.19x | 14.92x |
Forward P/E | 6.6x | -- | -- | -- |
Price to Sales | 0.75x | 1.16x | 1.38x | 1.34x |
Price to Book | 1.08x | 1.24x | 1.52x | 1.58x |
EV/Revenue | 1.05x | 1.59x | 1.79x | 1.7x |
EV/EBITDA | 4.6x | 7.04x | 8.28x | 8.03x |
Price to FCF (P/FCF) | 29.06x | 12.47x | 13.31x | 12.32x |
EV/FCF | 40.82x | 17.02x | 17.24x | 15.68x |
FCF Yield | 3.44% | 8.02% | 7.51% | 8.12% |